DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc., plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.
Collaborate Disseminate
DeepMind, the London-based artificial intelligence company that is owned by Alphabet Inc., plans to develop a medical product that will help doctors to detect more than 50 sight-threatening conditions from a common type of eye scan.